APO Research

APO RESEARCH · REPORT

Patient-Centric Healthcare App

Selected research

Market Outlook & Growth Opportunities

Global Patient-Centric Healthcare App Market Outlook and Growth Opportunities 2026

Market perspective

The global Patient-Centric Healthcare App market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Patient-Centric Healthcare App is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Patient-Centric Healthcare App is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Patient-Centric Healthcare App is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Patient-Centric Healthcare App market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Patient-Centric Healthcare App market include Bayer AG, Novartis AG, Siemens Healthineers AG, Pfizer Inc., Koninklijke Philips NV, MobileSmith Inc., Merck KgaA, MFine Pvt Ltd. and Athenahealth Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Patient-Centric Healthcare App market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Patient-Centric Healthcare App and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Patient-Centric Healthcare App revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Patient-Centric Healthcare App market.

Patient-Centric Healthcare App Segment by Company

Bayer AG

Novartis AG

Siemens Healthineers AG

Pfizer Inc.

Koninklijke Philips NV

MobileSmith Inc.

Merck KgaA

MFine Pvt Ltd.

Athenahealth Inc.

Oracle (Cerner Corporation)

ASSURECARE LLC (IPATIENT CARE)

Boston Scientific Corporation

International Business Machines Corporation (IBM)

Allscripts Healthcare Solutions Inc.

Baxter International Inc. (HillRom Services, Inc.)

Patient-Centric Healthcare App Segment by Type

Phone-based

Web-based

Hybrid Patient-centric Apps

Patient-Centric Healthcare App Segment by Application

Wellness Management

Disease and Therapy Management

Other

Patient-Centric Healthcare App Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Patient-Centric Healthcare App status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Patient-Centric Healthcare App key companies, revenue, market share, and recent developments.

3. To split the Patient-Centric Healthcare App breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Patient-Centric Healthcare App market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Patient-Centric Healthcare App significant trends, drivers, influence factors in global and regions.

6. To analyze Patient-Centric Healthcare App competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Patient-Centric Healthcare App market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Patient-Centric Healthcare App and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Patient-Centric Healthcare App.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Patient-Centric Healthcare App industry.

Chapter 3: Detailed analysis of Patient-Centric Healthcare App company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Patient-Centric Healthcare App in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Patient-Centric Healthcare App in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Patient-Centric Healthcare App Industry Trends Table 2. Patient-Centric Healthcare App Industry Drivers Table 3. Patient-Centric Healthcare App Industry Opportunities and Challenges Table 4. Patient-Centric Healthcare App Industry Restraints Table 5. Global Patient-Centric Healthcare App Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Patient-Centric Healthcare App Revenue Share by Company (2021-2026) Table 7. Global Patient-Centric Healthcare App Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Patient-Centric Healthcare App Key Company Manufacturing Base & Headquarters Table 9. Global Patient-Centric Healthcare App Company, Product Type & Application Table 10. Global Patient-Centric Healthcare App Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Patient-Centric Healthcare App by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Phone-based Table 15. Significant Companies of Web-based Table 16. Significant Companies of Hybrid Patient-centric Apps Table 17. Global Patient-Centric Healthcare App Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Patient-Centric Healthcare App Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Patient-Centric Healthcare App Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Patient-Centric Healthcare App Sales Value Share by Type (2021-2026) Table 21. Global Patient-Centric Healthcare App Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Wellness Management Table 23. Significant Companies of Disease and Therapy Management Table 24. Significant Companies of Other Table 25. Global Patient-Centric Healthcare App Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Patient-Centric Healthcare App Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Patient-Centric Healthcare App Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Patient-Centric Healthcare App Sales Value Share by Application (2021-2026) Table 29. Global Patient-Centric Healthcare App Sales Value Share by Application (2027-2032) Table 30. Global Patient-Centric Healthcare App Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Patient-Centric Healthcare App Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Patient-Centric Healthcare App Sales Value Share by Region (2021-2026) Table 33. Global Patient-Centric Healthcare App Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Patient-Centric Healthcare App Sales Value Share by Region (2027-2032) Table 35. Global Patient-Centric Healthcare App Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Patient-Centric Healthcare App Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Patient-Centric Healthcare App Sales Value Market Share by Country (2021-2026) Table 38. Global Patient-Centric Healthcare App Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Patient-Centric Healthcare App Sales Value Market Share by Country (2027-2032) Table 40. Bayer AG Company Information Table 41. Bayer AG Business Overview Table 42. Bayer AG Patient-Centric Healthcare App Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Bayer AG Patient-Centric Healthcare App Product Portfolio Table 44. Bayer AG Recent Development Table 45. Novartis AG Company Information Table 46. Novartis AG Business Overview Table 47. Novartis AG Patient-Centric Healthcare App Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Novartis AG Patient-Centric Healthcare App Product Portfolio Table 49. Novartis AG Recent Development Table 50. Siemens Healthineers AG Company Information Table 51. Siemens Healthineers AG Business Overview Table 52. Siemens Healthineers AG Patient-Centric Healthcare App Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Siemens Healthineers AG Patient-Centric Healthcare App Product Portfolio Table 54. Siemens Healthineers AG Recent Development Table 55. Pfizer Inc. Company Information Table 56. Pfizer Inc. Business Overview Table 57. Pfizer Inc. Patient-Centric Healthcare App Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Pfizer Inc. Patient-Centric Healthcare App Product Portfolio Table 59. Pfizer Inc. Recent Development Table 60. Koninklijke Philips NV Company Information Table 61. Koninklijke Philips NV Business Overview Table 62. Koninklijke Philips NV Patient-Centric Healthcare App Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Koninklijke Philips NV Patient-Centric Healthcare App Product Portfolio Table 64. Koninklijke Philips NV Recent Development Table 65. MobileSmith Inc. Company Information Table 66. MobileSmith Inc. Business Overview Table 67. MobileSmith Inc. Patient-Centric Healthcare App Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. MobileSmith Inc. Patient-Centric Healthcare App Product Portfolio Table 69. MobileSmith Inc. Recent Development Table 70. Merck KgaA Company Information Table 71. Merck KgaA Business Overview Table 72. Merck KgaA Patient-Centric Healthcare App Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Merck KgaA Patient-Centric Healthcare App Product Portfolio Table 74. Merck KgaA Recent Development Table 75. MFine Pvt Ltd. Company Information Table 76. MFine Pvt Ltd. Business Overview Table 77. MFine Pvt Ltd. Patient-Centric Healthcare App Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. MFine Pvt Ltd. Patient-Centric Healthcare App Product Portfolio Table 79. MFine Pvt Ltd. Recent Development Table 80. Athenahealth Inc. Company Information Table 81. Athenahealth Inc. Business Overview Table 82. Athenahealth Inc. Patient-Centric Healthcare App Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Athenahealth Inc. Patient-Centric Healthcare App Product Portfolio Table 84. Athenahealth Inc. Recent Development Table 85. Oracle (Cerner Corporation) Company Information Table 86. Oracle (Cerner Corporation) Business Overview Table 87. Oracle (Cerner Corporation) Patient-Centric Healthcare App Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Oracle (Cerner Corporation) Patient-Centric Healthcare App Product Portfolio Table 89. Oracle (Cerner Corporation) Recent Development Table 90. ASSURECARE LLC (IPATIENT CARE) Company Information Table 91. ASSURECARE LLC (IPATIENT CARE) Business Overview Table 92. ASSURECARE LLC (IPATIENT CARE) Patient-Centric Healthcare App Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. ASSURECARE LLC (IPATIENT CARE) Patient-Centric Healthcare App Product Portfolio Table 94. ASSURECARE LLC (IPATIENT CARE) Recent Development Table 95. Boston Scientific Corporation Company Information Table 96. Boston Scientific Corporation Business Overview Table 97. Boston Scientific Corporation Patient-Centric Healthcare App Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Boston Scientific Corporation Patient-Centric Healthcare App Product Portfolio Table 99. Boston Scientific Corporation Recent Development Table 100. International Business Machines Corporation (IBM) Company Information Table 101. International Business Machines Corporation (IBM) Business Overview Table 102. International Business Machines Corporation (IBM) Patient-Centric Healthcare App Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. International Business Machines Corporation (IBM) Patient-Centric Healthcare App Product Portfolio Table 104. International Business Machines Corporation (IBM) Recent Development Table 105. Allscripts Healthcare Solutions Inc. Company Information Table 106. Allscripts Healthcare Solutions Inc. Business Overview Table 107. Allscripts Healthcare Solutions Inc. Patient-Centric Healthcare App Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Allscripts Healthcare Solutions Inc. Patient-Centric Healthcare App Product Portfolio Table 109. Allscripts Healthcare Solutions Inc. Recent Development Table 110. Baxter International Inc. (HillRom Services, Inc.) Company Information Table 111. Baxter International Inc. (HillRom Services, Inc.) Business Overview Table 112. Baxter International Inc. (HillRom Services, Inc.) Patient-Centric Healthcare App Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Baxter International Inc. (HillRom Services, Inc.) Patient-Centric Healthcare App Product Portfolio Table 114. Baxter International Inc. (HillRom Services, Inc.) Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Patient-Centric Healthcare App Product Image Figure 2. Global Patient-Centric Healthcare App Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Patient-Centric Healthcare App Market Size (2021-2032) & (US$ Million) Figure 4. Global Patient-Centric Healthcare App Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Phone-based Image Figure 8. Web-based Image Figure 9. Hybrid Patient-centric Apps Image Figure 10. Global Patient-Centric Healthcare App Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Patient-Centric Healthcare App Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Patient-Centric Healthcare App Sales Value Share by Type (2021-2032) Figure 13. Wellness Management Image Figure 14. Disease and Therapy Management Image Figure 15. Other Image Figure 16. Global Patient-Centric Healthcare App Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Patient-Centric Healthcare App Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Patient-Centric Healthcare App Sales Value Share by Application (2021-2032) Figure 19. Global Patient-Centric Healthcare App Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Patient-Centric Healthcare App Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Patient-Centric Healthcare App Sales Value (2021-2032) & (US$ Million) Figure 22. North America Patient-Centric Healthcare App Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Patient-Centric Healthcare App Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Patient-Centric Healthcare App Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Patient-Centric Healthcare App Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Patient-Centric Healthcare App Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Patient-Centric Healthcare App Sales Value (2021-2032) & (US$ Million) Figure 28. South America Patient-Centric Healthcare App Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Patient-Centric Healthcare App Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Patient-Centric Healthcare App Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Phone-based
  • Web-based
  • Hybrid Patient-centric Apps
Applications
  • Wellness Management
  • Disease and Therapy Management
  • Other
Companies covered
  • Bayer AG
  • Novartis AG
  • Siemens Healthineers AG
  • Pfizer Inc.
  • Koninklijke Philips NV
  • MobileSmith Inc.
  • Merck KgaA
  • MFine Pvt Ltd.
  • Athenahealth Inc.
  • Oracle (Cerner Corporation)
  • ASSURECARE LLC (IPATIENT CARE)
  • Boston Scientific Corporation
  • International Business Machines Corporation (IBM)
  • Allscripts Healthcare Solutions Inc.
  • Baxter International Inc. (HillRom Services, Inc.)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Patient-Centric Healthcare App Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Patient-Centric Healthcare App Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Patient-Centric Healthcare App Market Dynamics
  1. 2.1 Patient-Centric Healthcare App Industry Trends
  2. 2.2 Patient-Centric Healthcare App Industry Drivers
  3. 2.3 Patient-Centric Healthcare App Industry Opportunities and Challenges
  4. 2.4 Patient-Centric Healthcare App Industry Restraints
3 Patient-Centric Healthcare App Market by Company
  1. 3.1 Global Patient-Centric Healthcare App Company Revenue Ranking in 2025
  2. 3.2 Global Patient-Centric Healthcare App Revenue by Company (2021-2026)
  3. 3.3 Global Patient-Centric Healthcare App Company Ranking (2024-2026)
  4. 3.4 Global Patient-Centric Healthcare App Company Manufacturing Base and Headquarters
  5. 3.5 Global Patient-Centric Healthcare App Company Product Type and Application
  6. 3.6 Global Patient-Centric Healthcare App Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Patient-Centric Healthcare App Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Patient-Centric Healthcare App Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Patient-Centric Healthcare App Market by Type
  1. 4.1 Patient-Centric Healthcare App Type Introduction
  2. 4.1.1 Phone-based
  3. 4.1.2 Web-based
  4. 4.1.3 Hybrid Patient-centric Apps
  5. 4.2 Global Patient-Centric Healthcare App Sales Value by Type
  6. 4.2.1 Global Patient-Centric Healthcare App Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Patient-Centric Healthcare App Sales Value by Type (2021-2032)
  8. 4.2.3 Global Patient-Centric Healthcare App Sales Value Share by Type (2021-2032)
5 Patient-Centric Healthcare App Market by Application
  1. 5.1 Patient-Centric Healthcare App Application Introduction
  2. 5.1.1 Wellness Management
  3. 5.1.2 Disease and Therapy Management
  4. 5.1.3 Other
  5. 5.2 Global Patient-Centric Healthcare App Sales Value by Application
  6. 5.2.1 Global Patient-Centric Healthcare App Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Patient-Centric Healthcare App Sales Value by Application (2021-2032)
  8. 5.2.3 Global Patient-Centric Healthcare App Sales Value Share by Application (2021-2032)
6 Patient-Centric Healthcare App Regional Value Analysis
  1. 6.1 Global Patient-Centric Healthcare App Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Patient-Centric Healthcare App Sales Value by Region (2021-2032)
  3. 6.2.1 Global Patient-Centric Healthcare App Sales Value by Region: 2021-2026
  4. 6.2.2 Global Patient-Centric Healthcare App Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Patient-Centric Healthcare App Sales Value (2021-2032)
  7. 6.3.2 North America Patient-Centric Healthcare App Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Patient-Centric Healthcare App Sales Value (2021-2032)
  10. 6.4.2 Europe Patient-Centric Healthcare App Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Patient-Centric Healthcare App Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Patient-Centric Healthcare App Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Patient-Centric Healthcare App Sales Value (2021-2032)
  16. 6.6.2 South America Patient-Centric Healthcare App Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Patient-Centric Healthcare App Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Patient-Centric Healthcare App Sales Value Share by Country, 2025 VS 2032
7 Patient-Centric Healthcare App Country-level Value Analysis
  1. 7.1 Global Patient-Centric Healthcare App Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Patient-Centric Healthcare App Sales Value by Country (2021-2032)
  3. 7.2.1 Global Patient-Centric Healthcare App Sales Value by Country (2021-2026)
  4. 7.2.2 Global Patient-Centric Healthcare App Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Patient-Centric Healthcare App Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Patient-Centric Healthcare App Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Patient-Centric Healthcare App Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer AG
  2. 8.1.1 Bayer AG Company Information
  3. 8.1.2 Bayer AG Business Overview
  4. 8.1.3 Bayer AG Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bayer AG Patient-Centric Healthcare App Product Portfolio
  6. 8.1.5 Bayer AG Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Patient-Centric Healthcare App Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Siemens Healthineers AG
  14. 8.3.1 Siemens Healthineers AG Company Information
  15. 8.3.2 Siemens Healthineers AG Business Overview
  16. 8.3.3 Siemens Healthineers AG Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Siemens Healthineers AG Patient-Centric Healthcare App Product Portfolio
  18. 8.3.5 Siemens Healthineers AG Recent Developments
  19. 8.4 Pfizer Inc.
  20. 8.4.1 Pfizer Inc. Company Information
  21. 8.4.2 Pfizer Inc. Business Overview
  22. 8.4.3 Pfizer Inc. Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Inc. Patient-Centric Healthcare App Product Portfolio
  24. 8.4.5 Pfizer Inc. Recent Developments
  25. 8.5 Koninklijke Philips NV
  26. 8.5.1 Koninklijke Philips NV Company Information
  27. 8.5.2 Koninklijke Philips NV Business Overview
  28. 8.5.3 Koninklijke Philips NV Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Koninklijke Philips NV Patient-Centric Healthcare App Product Portfolio
  30. 8.5.5 Koninklijke Philips NV Recent Developments
  31. 8.6 MobileSmith Inc.
  32. 8.6.1 MobileSmith Inc. Company Information
  33. 8.6.2 MobileSmith Inc. Business Overview
  34. 8.6.3 MobileSmith Inc. Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MobileSmith Inc. Patient-Centric Healthcare App Product Portfolio
  36. 8.6.5 MobileSmith Inc. Recent Developments
  37. 8.7 Merck KgaA
  38. 8.7.1 Merck KgaA Company Information
  39. 8.7.2 Merck KgaA Business Overview
  40. 8.7.3 Merck KgaA Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck KgaA Patient-Centric Healthcare App Product Portfolio
  42. 8.7.5 Merck KgaA Recent Developments
  43. 8.8 MFine Pvt Ltd.
  44. 8.8.1 MFine Pvt Ltd. Company Information
  45. 8.8.2 MFine Pvt Ltd. Business Overview
  46. 8.8.3 MFine Pvt Ltd. Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MFine Pvt Ltd. Patient-Centric Healthcare App Product Portfolio
  48. 8.8.5 MFine Pvt Ltd. Recent Developments
  49. 8.9 Athenahealth Inc.
  50. 8.9.1 Athenahealth Inc. Company Information
  51. 8.9.2 Athenahealth Inc. Business Overview
  52. 8.9.3 Athenahealth Inc. Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Athenahealth Inc. Patient-Centric Healthcare App Product Portfolio
  54. 8.9.5 Athenahealth Inc. Recent Developments
  55. 8.10 Oracle (Cerner Corporation)
  56. 8.10.1 Oracle (Cerner Corporation) Company Information
  57. 8.10.2 Oracle (Cerner Corporation) Business Overview
  58. 8.10.3 Oracle (Cerner Corporation) Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Oracle (Cerner Corporation) Patient-Centric Healthcare App Product Portfolio
  60. 8.10.5 Oracle (Cerner Corporation) Recent Developments
  61. 8.11 ASSURECARE LLC (IPATIENT CARE)
  62. 8.11.1 ASSURECARE LLC (IPATIENT CARE) Company Information
  63. 8.11.2 ASSURECARE LLC (IPATIENT CARE) Business Overview
  64. 8.11.3 ASSURECARE LLC (IPATIENT CARE) Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ASSURECARE LLC (IPATIENT CARE) Patient-Centric Healthcare App Product Portfolio
  66. 8.11.5 ASSURECARE LLC (IPATIENT CARE) Recent Developments
  67. 8.12 Boston Scientific Corporation
  68. 8.12.1 Boston Scientific Corporation Company Information
  69. 8.12.2 Boston Scientific Corporation Business Overview
  70. 8.12.3 Boston Scientific Corporation Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Boston Scientific Corporation Patient-Centric Healthcare App Product Portfolio
  72. 8.12.5 Boston Scientific Corporation Recent Developments
  73. 8.13 International Business Machines Corporation (IBM)
  74. 8.13.1 International Business Machines Corporation (IBM) Company Information
  75. 8.13.2 International Business Machines Corporation (IBM) Business Overview
  76. 8.13.3 International Business Machines Corporation (IBM) Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  77. 8.13.4 International Business Machines Corporation (IBM) Patient-Centric Healthcare App Product Portfolio
  78. 8.13.5 International Business Machines Corporation (IBM) Recent Developments
  79. 8.14 Allscripts Healthcare Solutions Inc.
  80. 8.14.1 Allscripts Healthcare Solutions Inc. Company Information
  81. 8.14.2 Allscripts Healthcare Solutions Inc. Business Overview
  82. 8.14.3 Allscripts Healthcare Solutions Inc. Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Allscripts Healthcare Solutions Inc. Patient-Centric Healthcare App Product Portfolio
  84. 8.14.5 Allscripts Healthcare Solutions Inc. Recent Developments
  85. 8.15 Baxter International Inc. (HillRom Services, Inc.)
  86. 8.15.1 Baxter International Inc. (HillRom Services, Inc.) Company Information
  87. 8.15.2 Baxter International Inc. (HillRom Services, Inc.) Business Overview
  88. 8.15.3 Baxter International Inc. (HillRom Services, Inc.) Patient-Centric Healthcare App Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Baxter International Inc. (HillRom Services, Inc.) Patient-Centric Healthcare App Product Portfolio
  90. 8.15.5 Baxter International Inc. (HillRom Services, Inc.) Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research